Ann Intern Med
- KIM GA, Lim YS
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic
Patients With Chronic Hepatitis B.
Ann Intern Med. 2025;178:1365-1366.
- HUANG SC, Kao JH
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic
Patients With Chronic Hepatitis B.
Ann Intern Med. 2025;178:1364.
- WANG J, Pan Y, Fan T, Wu C, et al
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic
Patients With Chronic Hepatitis B.
Ann Intern Med. 2025;178:1364-1365.
Hepatology
- GOMEZ-ESCOBAR E, Flores N, Shoukry NH
One step closer to a pan-genotypic hepatitis C vaccine.
Hepatology. 2025 Sep 17. doi: 10.1097/HEP.0000000000001530.
- KELLERMAYER R, Carbone M, Horvath TD, Szigeti RG, et al
Identifying a therapeutic window of opportunity for people living with primary
sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease
with immune mediated liver injury.
Hepatology. 2024 May 14. doi: 10.1097/HEP.0000000000000926.
J Viral Hepat
- WONG RJ, Yang Z, Lim J, Jou JH, et al
High Prevalence of Cirrhosis or Hepatocellular Carcinoma at Hepatitis Delta
Infection Diagnosis Reflects Alarming Delays in Testing.
J Viral Hepat. 2025;32:e70086.
- CHAU A, Li J, Jun DW, Hsu YC, et al
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment
Response to Nucleos(t)ide Analogs.
J Viral Hepat. 2025;32:e70081.
- ZHANG L, Ji H, Pang S, Yan Y, et al
Identifying Adherence Trajectories in Chronic Hepatitis B: A Cluster-Based
Approach to Long-Term Treatment Management.
J Viral Hepat. 2025;32:e70068.
- VOJT G, Bonnet P, Scott J, Hathorn E, et al
Peer-Delivered Outreach With Rapid Treatment Pathways for Hepatitis C Testing and
Treatment Among Unhoused People.
J Viral Hepat. 2025;32:e70085.
- BUGSSA G, Teklehaymanot T, Medhin G, Nayagam S, et al
Prevalence and Factors Associated With Hepatitis B Virus Infection in Tigray
Region, Northern Ethiopia.
J Viral Hepat. 2025;32:e70077.
- YAN L, Yuan M, Su M, Cui K, et al
U-Shaped Relationship Between CT-Measured Liver-To-Spleen Volume Ratio and
Mortality in HBV-ACLF Patients.
J Viral Hepat. 2025;32:e70076.
- BHATIA P, Mohd A, Katiyar H, Goel A, et al
Longitudinal Profiles of Cytokines and Chemokines in Self-Limiting Hepatitis E.
J Viral Hepat. 2025;32:e70088.
J Virol
- DING Y, Li Q, Sha Y, Si R, et al
Multimodal characterization of the responsiveness of eight hepatitis D virus
genotype isolates to interferon-alpha treatment.
J Virol. 2025 Sep 18:e0128025. doi: 10.1128/jvi.01280.
PLoS One
- CHEN L, Lu Z, Zhang X, Lai J, et al
Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA
double-negative lymphoma patients.
PLoS One. 2025;20:e0332421.
- ADJEI-ROGER J, Afagbedzi S, Tei-Maya E, Guure C, et al
Evaluation of statistical regression models in predicting factors influencing HBV
and HIV among female sex workers in Ghana: A Bio-behavioural survey.
PLoS One. 2025;20:e0332152.
Vaccine
- GAO S, Cai M, Su M, Zhao T, et al
Influencing factors and trends in post-vaccination serologic testing completion
rates among infants born to HBsAg-positive mothers in Guangdong Province,
2021-2023.
Vaccine. 2025;62:127565.
- KANG W, Wang F, Hao Z, Zhang Z, et al
A follow-up study on the protective efficacy and anamnestic response of
recombinant CHO hepatitis B vaccine 26 years after immunization.
Vaccine. 2025;64:127743.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016